The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: LAMIVUDINE.     Injury: Foetal exposure during pregnancy     Quarter: 2016Q3

  |<   1/2   << Previous Page   Page 4  

Total Records: 70     Number of Pages: 4

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
127982441 LAMIVUDINE. Foetal exposure during pregnancy CIPLA 0.00 0 20160930 US
127982801 LAMIVUDINE. Foetal exposure during pregnancy CIPLA 0.00 0 20160930 US
127982901 LAMIVUDINE. Foetal exposure during pregnancy CIPLA 0.00 0 20160930 US
127985861 LAMIVUDINE. Foetal exposure during pregnancy CIPLA 0.00 0 20160930 US
127985931 LAMIVUDINE. Foetal exposure during pregnancy CIPLA 0.00 0 20160930 US
127986481 LAMIVUDINE. Foetal exposure during pregnancy CIPLA 0.00 0 20160930 US
127986611 LAMIVUDINE. Foetal exposure during pregnancy CIPLA 0.00 0 20160930 US
127986901 LAMIVUDINE. Foetal exposure during pregnancy CIPLA 0.00 0 20160930 US
127986951 LAMIVUDINE. Foetal exposure during pregnancy CIPLA 0.00 0 20160930 US
127987731 LAMIVUDINE. Foetal exposure during pregnancy CIPLA 0.00 0 20160930 US

  |<   1/2   << Previous Page   Page 4  

Total Records: 70     Number of Pages: 4

Execution Time: 0.013397932052612 seconds (ucode:5253713). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.